Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (AMD3100)

This study is not yet open for participant recruitment.
Verified May 2011 by New York University School of Medicine
Sponsor:
Collaborators:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Stephen Warren, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01353937
First received: May 12, 2011
Last updated: April 25, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)